Adjusting Your Insulin Pump When Starting a GLP-1 Medication

Starting a GLP-1 receptor agonist (GLP-1a) like Mounjaro, Ozempic, or Victoza can lead to meaningful improvements in blood sugar, weight, and appetite control. However, if you use an insulin pump, you’ll likely need to adjust your insulin doses to avoid low blood sugar as your body responds to this new medication.

Let’s walk through what to expect—and how to work with your care team to make smart adjustments.

Why GLP-1 Medications Affect Insulin Needs

GLP-1 medications work by enhancing your body’s own insulin response, especially after meals. They also delay stomach emptying and reduce appetite. For patients with type 1 or type 2 diabetes on insulin pumps, this can lower blood sugar more than expected.

Even small changes in how much food you eat or how fast glucose enters your bloodstream can lead to mismatches between your insulin delivery and your actual needs.

As a result, most patients will need to lower their insulin doses—especially meal boluses—when starting a GLP-1.

Common Adjustments to Insulin Pump Settings

Your insulin pump has multiple settings that may require change. The most common adjustments involve bolus doses, carb ratios, and correction factors. Basal changes are also possible, depending on your patterns.

Before listing the changes, here’s a simple overview:

When you start a GLP-1, your post-meal glucose peaks tend to flatten, and your total food intake often decreases. This means the same insulin dose may now be too much, increasing the risk of hypoglycemia.

Here’s how your pump settings may need to change:

1. Meal Boluses / Carb Ratios

You may need less insulin per gram of carbohydrate because GLP-1 medications reduce glucose spikes after eating.

• Example: If your previous carb ratio was 1 unit per 10 grams of carbs, you may now need 1 unit per 12–15 grams.
• Watch for lows 1–3 hours after meals—this suggests the current dose is too high.

2. Correction Factor / Insulin Sensitivity

You may become more insulin sensitive, especially as weight and inflammation decrease.

• Example: If 1 unit used to drop your sugar by 50 mg/dL, it may now lower it by 60–70 mg/dL.
• This is especially important for patients who manually correct highs or use hybrid closed-loop systems.

3. Basal Rates

Some patients need slightly lower basal rates over time, especially if fasting lows occur or if meals are skipped more often.

• Check overnight and pre-breakfast patterns.
• Use temporary basal rates as a short-term solution until a new pattern is clear.

4. Active Insulin Time (Duration of Insulin Action)

Some pump users find that a longer duration of insulin activity better matches their new physiology.

• You might extend this from 3 hours to 4 hours.
• This helps avoid insulin stacking and late post-meal lows.

Summary Table

Here’s a quick reference:

Setting Type	Common Adjustment	Reason for Change
Carb Ratio	Lower insulin per gram (e.g., 1:12–1:15 instead of 1:10)	Smaller meals, slower gastric emptying, and less post-meal glucose rise
Correction Factor	Increased sensitivity (e.g., 1:65 instead of 1:50)	Weight loss and improved insulin action enhance responsiveness to correction insulin
Basal Rates	10–20% reduction in some time blocks	Reduced appetite and skipped meals can make prior basal levels too strong
Active Insulin Time	Increase duration (e.g., from 3 to 4 hours)	Delayed digestion means insulin acts over a longer curve—reducing late post-meal lows
Bolus Timing	May need to shift closer to or even after meals	Slower stomach emptying delays glucose absorption; earlier insulin timing may cause lows
Temporary Basal	Use 10–30% reduction for 2–4 hours post-injection or with missed meals	Prevents lows when food intake is uncertain or reduced following GLP-1 administration
Meal Frequency	Less frequent meals—may skip breakfast or lunch	Appetite suppression can change daily insulin rhythm; adjust boluses accordingly

Real-World Examples from Practice

A 38-year-old man with type 1 diabetes and mild insulin resistance started semaglutide. Within 2 weeks, he noticed frequent post-breakfast lows. His morning carb ratio was adjusted from 1:10 to 1:14, which restored stability.

A 47-year-old woman with type 2 diabetes on an insulin pump began tirzepatide. She began eating smaller meals and unintentionally skipped lunch twice in one week. Her afternoon basal rate was reduced by 20%, and her correction factor was increased from 1:50 to 1:65.

A 29-year-old man with type 1 diabetes used a closed-loop system and started liraglutide. He noted lower overall insulin needs and frequent overnight lows. His overnight basal rate was reduced by 15%, and his insulin action duration was extended from 3 to 4 hours.

A 62-year-old woman with LADA started dulaglutide. She needed fewer corrections during the day, but post-dinner lows increased. Her dinner carb ratio changed from 1:8 to 1:12, and her pre-dinner bolus timing was moved closer to meals.

A 43-year-old man with obesity and insulin pump therapy reduced his total daily dose by 30% within the first month of GLP-1 use. His basal-to-bolus ratio shifted from 50:50 to 60:40, reflecting smaller meal boluses and stronger fasting control.

Tips for a Safe Transition

Adjustments should always be guided by careful glucose tracking and close coordination with your diabetes specialist.

Here’s how to navigate the first 4 weeks:

• Use a CGM if available for real-time trend data.
• Log meals, doses, and timing to detect patterns.
• Avoid large corrections during the first 1–2 weeks.
• Use temp basal reductions (10–20%) when in doubt.
• Expect needs to evolve over the next 6–12 weeks as your body adapts.

Why Holistic, Individualized Care Matters

Adjusting insulin pump settings isn’t just about numbers—it’s about understanding how hormones, digestion, and lifestyle shift in tandem. At our practice in Montgomery County, Maryland, we look at care from multiple angles: GLP-1 effects, meal patterns, activity, and insulin sensitivity. We approach these transitions with thoughtful care—tailoring decisions for each person, not just each pump.

Virtual support is also available for patients across the country who want safe, smart, and personalized strategies during this transition.